Aditxt earnings were -$37.2M for the trailing 12 months ending Mar 31, 2025, with -85.3% growth year over year. The latest ADTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.7M, up 9.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADTX reported annual earnings of -$46.3M, with 40.1% growth.
ADTX past earnings growth
How has ADTX's earnings growth performed historically?
On ADTX's earnings call on Invalid Date, Aditxt (NASDAQ: ADTX) reported Q1 2025 earnings per share (EPS) of -$8.12, up 99.99% year over year. Total ADTX earnings for the quarter were -$5.71 million. In the same quarter last year, Aditxt's earnings per share (EPS) was -$91,439.43.
As of the last Aditxt earnings report, Aditxt is currently losing money. Aditxt's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$31.33 million, a 24.4% decrease year over year.
What was ADTX's earnings growth in the past year?
As of Aditxt's earnings date in Invalid Date, Aditxt's earnings has grown -85.33% year over year. This is 96.86 percentage points lower than the US Biotechnology industry earnings growth rate of 11.53%. ADTX earnings in the past year totalled -$37.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.